Bangalore, India, 560085
This combination tablet is a prescription antidiabetic medication formulated to manage type 2 diabetes mellitus. It combines three effective agents: Dapagliflozin Propanediol Monohydrate 10 mg – an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys, promoting glucose excretion through urine. Vildagliptin 100 mg – a DPP-4 inhibitor that enhances insulin secretion and suppresses glucagon release in a glucose-dependent manner. Metformin Hydrochloride IP 500 mg (SR) – a sustained-release biguanide that improves insulin sensitivity, reduces hepatic glucose production, and controls blood sugar levels steadily. Together, this triple therapy works synergistically to achieve optimal glycemic control, support weight management, and reduce the risk of diabetes-related complications.